Financial and Insurance Assistance- Oncology Financial and Legal Navigation Program
Study Details
Study Description
Brief Summary
The overall objective of this study was to develop and evaluate FINassist (Financial and Insurance Navigation Assistance), a patient-centered, interdisciplinary team-based oncology financial and legal navigation program. The program leverages Medical Legal Partnerships to enhance cost of care conversations with pediatric oncology patients and caregivers. FINassist optimizes the team-based care model by integrating clinicians, social workers, financial navigators, and legal advocates who work in tandem to enhance cost of care conversations with patients and caregivers, identify and intervene on patient socio-legal needs, and advocate for system-level changes.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Financial Navigation and Insurance Assistance (FINassist) Patient Only Patients only participated in FINassist program |
Other: FINassist
The FINassist intervention provides access to social, financial and legal services over the duration of 12 months or until issues are resolved
|
| Experimental: Financial Navigation and Insurance Assistance (FINassist) Patient Caregiver Caregivers of minor patients only participated in FINassist program |
Other: FINassist
The FINassist intervention provides access to social, financial and legal services over the duration of 12 months or until issues are resolved
|
Outcome Measures
Primary Outcome Measures
- FINassist Feasibility [12 months]
Feasibility is defined by number of participants enrolled
- FINassist Adherence [through issue resolution up to 12 months]
Adherence is defined by the percentage of participants that maintain communication with the team and provide documents necessary for issue resolution
- FINassist Retention [through study completion up to 12 months]
percentage of participants that complete both pre and post-intervention surveys
- FINassist Acceptability [Post intervention at 12 months]
Acceptability is measured using a 5 item post-intervention survey of relevance, helpfulness, convenience, recommendation to others, and value. Ratings on a scale from 0 to 10 where a higher score means greater acceptability
- Change in Financial Toxicity [Baseline and post intervention, approximately 12 weeks]
Measured using the COmprehensive Score for financial Toxicity (COST) tool, a measure that describes the financial distress experienced by cancer patients. Scores range from 0-44 with a higher score representing better financial well-being.
- Change in Participant Quality of Life (physical and mental) [Baseline and post intervention, approximately 12 weeks]
Measured using the 10-item PROMIS® (Patient-Reported Outcomes Measurement Information System) Parent Proxy Global Health scale. A 7-item summary assessment of a child's self-reported health with higher scores representing better quality of life.
- Change in Participant Quality of Life (Depression) [Baseline and post intervention, approximately 12 weeks]
Measured using the 6-item Patient-Reported Outcomes Measurement Information System PROMIS® Depression Short Form. Scores range from 6 to 30. Higher scores indicate more of the construct being measured.
- Change in Participant Quality of Life (Anxiety) [Baseline and post intervention, approximately 12 weeks]
Measured using the 4-item Patient-Reported Outcomes Measurement Information System PROMIS® Anxiety short form. Scores range from 4 to 20. Higher scores indicate more of the construct being measured.
- Change in Patient-Provider Trust [Baseline and post intervention, approximately 12 weeks]
Measured using the the Health Care Relationship (HCR) Trust Scale. The HCR-Trust scale is scored from 0 to 4 with a maximum score of 52. Higher scores represent more trust in healthcare providers
- Resolution of Socio-legal Issue [12 months]
Number of participants that resolved a legal or financial case as a result of FINassist
Secondary Outcome Measures
- Number of Participants Receiving Financial Benefit [12 months]
financial benefit defined as economic hardship avoided or decreased public/government income
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Caregivers of patients who have any cancer or hematologic disorder diagnosis at the DanceBlue Pediatric Hematology/oncology clinic at Kentucky Children's hospital
-
Patients with childhood cancers and/or hematologic disorders at the DanceBlue Pediatric Hematology/oncology clinic at Kentucky Children's hospital
-
18 years and older
Exclusion Criteria:
- Unable to provide consent
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Kentucky DanceBlue Pediatric Hematology/oncology clinic | Lexington | Kentucky | United States | 40506 |
Sponsors and Collaborators
- Jean Edward
- Robert Wood Johnson Foundation
Investigators
- Principal Investigator: Jean Edward, PhD, RN, University of Kentucky
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 57238